⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001843748

D'Angio Paul

Reports to the SEC for 1 company · GAITHERSBURG, MD

Transactions

17

Companies

1

Filings

5

CIK

0001843748

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-07-05	NexImmune, Inc.Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	44,983
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−61.7K sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Director	AAward	+61.7K sh	—	—	61,678
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,556 sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,556 sh	—	—	9,556
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.1K sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Director	AAward	+23.1K sh	—	—	23,122
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.6K sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Director	AAward	+12.6K sh	—	—	12,634
2022-06-13	NexImmune, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+61.7K sh	—	—	61,678
2021-02-17	NexImmune, Inc.C Conversion	Director	CConversion	+19.6K sh	—	—	19,627
2021-02-17	NexImmune, Inc.C Conversion	Director	CConversion	+4,110 sh	—	—	23,737
2021-02-17	NexImmune, Inc.C Conversion	Director	CConversion	+4,110 sh	—	—	27,847
2021-02-17	NexImmune, Inc.Series A Preferred StockC Conversion	Director	CConversion	−19.6K sh	—	—	0
2021-02-17	NexImmune, Inc.Series A2 Preferred StockC Conversion	Director	CConversion	−4,110 sh	—	—	0
2021-02-17	NexImmune, Inc.Series A3 Preferred StockC Conversion	Director	CConversion	−4,110 sh	—	—	0
2021-02-11	NexImmune, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,556 sh	—	—	45,312

Recent filings

5

Accepted (ET)
Jul 74
D'Angio Paul0000950170-23-032244
SEC(opens sec.gov)
Apr 64
D'Angio Paul0001209191-23-023683
SEC(opens sec.gov)
Jun 154
D'Angio Paul0001209191-22-037014
SEC(opens sec.gov)
Feb 194
D'Angio Paul0001209191-21-012359
SEC(opens sec.gov)
Feb 164
D'Angio Paul0001209191-21-010667
SEC(opens sec.gov)

Companies

1

NexImmune, Inc.Director

Address

C/O NEXIMMUNE, INC. 9119 GAITHER ROAD

GAITHERSBURG, MD, 20877